CYTOREDUCTIVE SURGERY BEFORE HIGH DOSE INTERLEUKIN-2 BASED THERAPY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
- 1 November 1997
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 158 (5) , 1675-1678
- https://doi.org/10.1016/s0022-5347(01)64091-6
Abstract
Purpose: We defined the outcome of a strategy using cytoreductive surgery before high dose interleukin-2 (IL-2) therapy in patients with metastatic renal cell carcinoma.Materials and Method...Keywords
This publication has 25 references indexed in Scilit:
- Cytoreductive Surgery for Stage IV Renal Cell CarcinomaJournal of Urology, 1995
- The Impact Of Adjuvant Nephrectomy On Multimodality Treatment Of Metastatic Renal Cell CarcinomaJournal of Urology, 1994
- Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinomaUrology, 1993
- Regression of Metastatic Renal Cell Carcinoma After Cytoreductive NephrectomyJournal of Urology, 1993
- Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinomaUrology, 1991
- Preparative Cytoreductive Surgery in Patients with Metastatic Renal Cell Carcinoma Treated with Adoptive Immunotherapy with Interleukin-2 or Interleukin-2 Plus Lymphokine Activated Killer CellsJournal of Urology, 1990
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- Is Nephrectomy Justified in Patients with Metastatic Renal Carcinoma?Journal of Urology, 1975
- Diagnosis and management of renal cell carcinomaA clinical and pathologic study of 309 casesCancer, 1971
- Surgery for Metastatic Renal Cell CarcinomaJournal of Urology, 1967